(For many reasons other than this as well, I wish John were still around so I could ask if I could post some excerpts of that article...) Kraemer WJ, Spiering BA, Volek JS, Ratamess NA, Sharman MJ, Rubin MR, French DN, Silvestre R, Hatfield DL, Van Heest JL, Vingren JL, Judelson DA, Deschenes MR, and Maresh CM
Here we discuss the main ideas involved in modeling the transsulfuration pathway, referring the reader to [20] (and its online supplementary material) for a discussion of the other parts of the model
Company founder Brigham Buhler is a former pharmaceutical sales rep
Miner SE, Dzavik V, Nguyen-Ho P, Richardson R, Mitchell J, Atchison D, Seidelin P, Daly P, Ross J, McLaughlin PR, Ing D, Lewycky P, Barolet A, Schwartz L